Built and running a new department from scratch to lead exchange institutional-investor push. Identifying new business opportunities, developing partnerships, and maintaining relationships with prop trading firms, asset managers, brokers, custodians to ensure the long-term growth and success of the exchange.Developing and implementing effective market campaign strategies to promote the exchange's products and services, raise awareness of the brand, and build a positive reputation in the industry.

Tradeweb is the first offshore trading platform to connect with China Foreign Exchange Trade System (CFETS), becoming the main trading interface for international investors to access China bond market. Developing business strategies and growth plans for Tradeweb to become the electronic trading link to China markets. Managing all aspects of Bond Connect Initiative and owning project’s P&L. Increased the volume and revenue for more than 50% in 2019.Building relationships with local government agencies, dealers, financial infrastructures and industry groups, and representing Tradeweb to advocate and achieve market structure improvements. Working closely with management team in regulatory oversight and managing regulatory impact and influencing decision making in a cross-functional executive team.Leading partnership explorations/negotiations and providing insights on market development and networking relationships.

Joined the firm to build the China Financial Market practice providing advisory services to professional market participants looking for a one stop solution to access China markets.Research and analysis regarding new trends in the industry and regulatory requirements.Served as a consultative resource to management and trading team on legal, regulatory, tax and operational factors pertaining to accessing China markets.Worked with the clients to optimize their ultra-low latency trading strategies.

Led business development in China for CME Group with the development of Shanghai and CSRC outbound pilot program.Established representative office in Beijing and developed a 3 year “China Strategy” with an incremental budget of USD$ 12M.Managed all aspects of CME China business development; including partnering with internal and external stakeholders.Represented the interests of CME and delivered presentation in the main industry event; published articles to increase CME’s brand awareness and promote the best practice for the development of China derivatives markets.Articles published in China Futures’ Daily:- Customer Protection in US Derivatives Market- Introduction of Exchange and OTC Electronic Trading Platform- How to effectively internationalizing local market – CME’s experience Led assessment, negotiation, development and management of CME’s China strategic initiatives.Orchestrated the first exchange market data agreement with China Financial Futures Exchange from business case building, commercial contract negotiation, Board of Directors of two exchanges approval, regulatory approval from CSRC.Drove BOC’s first strategic partnership with international exchange resulting BOCI to become CME’s full clearing member; BOCNY to become CME’s settlement and RMB collateral band and BOC Singapore to become CME’s first offshore LOC bank.Established collaborative relationship with all China national exchanges and industry associations.Served as advisor for CSRC and PBOC on market and regulations development including consultation on the development of SHFE Crude Oil contract, the draft of China futures law, the flash crash event caused by Everbright securities.

Relocated to Singapore from Chicago and promoted to executive director from manager to lead the expansion of CME Clearing service in Asia. Managed expansion of CME’s global clearing membership in China, Hong Kong and Singapore.Directed regionally tailored client clearing services and collaboration with local custodian and settlement banks, regulators, and law firms.Primary lead for CME Clearing in collaboration with local regulators and industry during MF Global Crisis.Led the CME Group’s application of OTC clearing licenses in various Asia Pacific jurisdictions, including Hong Kong, Japan, Singapore and Australia.Represented CME in the regulatory consultations on OTC central clearing in HK, Japan, Australia, Singapore, and China.

Responsible for managing business development of clearing services opportunities in the Asia-Pacific region as well as sharing responsbilities for both short and long-term global strategic projects for the clearing division. Led the efforts in identify and pursue business development opportunities to grow CME Group's businesses in China; function as primary liaison with China stakeholders (i.e. exchanges, regulators, and market participants). Worked across the organizaion to develop and refine the approach for the provision of our services across assets classes, in the listed and OTC derivatives markets for domestic and intnernational customers.

Performed qualitative and quantitative analysis to assess market, credit and operational risk to the exchangeManaged and developed quantitative tools to evaluate and monitor counterparty exposures to the Clearing HouseResearched and promoted new strategies to increase capital efficiency and decrease collateral risk in our USD100 billion collateral management programEstablished position level margin requirements based on historic and quantitative risk models and reviewed portfolio margin coverage levels on a daily basis and market to market variations of firms

Conducted qualitative and quantitative analysis to manage market, credit and operational risks for Chicago Mercantile Exchange.Substantial interaction with banks and financial institutions to discuss their market and credit risk exposures. Promoted and supported SPAN system, provide risk management training to exchanges, regulators and financial institutions in Asia.

Assisted in trade execution, accounting and daily management of traders’ portfolios.Learned the full cycle of trading by working inextricably between front and back offices.

An infrastructure investment company owned by international investors including Temasek, RWE Thames Water and Sime Darby, has invested and operated 7 CJV and EJV contracts in China. 2-year experience in market and legal due dilligence, M&A transaction, statutory policies research for China direct investment, contract negotiation.